The 26th edition of the International Conference on Laboratory Medicine, held in Padova on October 23rd 2019, is entitled “From bench to diagnostic – therapeutic pathways”. Laboratory (diagnostic) services are a key component of modern health care. It has been estimated that 70–80% of all medical decisions impacting diagnosis or treatment involve at least one pathology and laboratory medicine (PALM) investigation. In this issue of the Journal, we publish a series of papers emphasizing the debate regarding the future of laboratory medicine, translational health economics and some examples of translating new biomarkers into clinical practice.
Navigating between technology and professionalism: key points for the future of clinical laboratories
Procalcitonin in acute infections: from the research laboratory to clinical impact—new perspectives of biomarker use
More are coming......